INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/19/2026
Back to search
Official data from USPTO
ALOFISEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
02/20/2026
Trademark type
Combined
Nice classes
5
Filing date
04/11/2017
Registration date
05/15/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2024
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
CH
Examiner
RYDLAND, STEPHANIE DIANA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ALOFISEL" in grey, with the "O" replaced with a grey circle containing a small light blue circle inside. Above the wording are two light blue circles with a single small grey circle inside each, and below the wording is a light blue circle with a single small grey circle inside.
Holders and representatives
Holders
Takeda Pharmaceuticals International AG
TIGENIX, S.A.U.
Representatives
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; cellularbiological or bacteriological preparations for medical purposesfor the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants or engineered live cellular tissue for medical purposesfor the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients
Publications
History of USPTO decisions and trademark events.
47 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/26/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
01/26/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/28/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/29/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/28/2025
C71T
CANCELLED SECTION 71
11/29/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/15/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/23/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
07/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/15/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/24/2018
FIMP
FINAL DISPOSITION PROCESSED
08/24/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/15/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/27/2018
PUBO
PUBLISHED FOR OPPOSITION
02/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2018
ALIE
ASSIGNED TO LIE
01/22/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
01/15/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/15/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
01/15/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/10/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/10/2018
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/18/2017
RFRR
REFUSAL PROCESSED BY MPU
07/18/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/15/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2017
CNRT
NON-FINAL ACTION WRITTEN
07/11/2017
DOCK
ASSIGNED TO EXAMINER
07/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2017
Continuous trademark protection
Get notified about every new filing that threatens ALOFISEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.